Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proteinase K (EC 3.4.21.64) is a highly active, broad-spectrum serine protease originally isolated from the fungus Engyodontium album [UniProt: P06873]. It belongs to the subtilisin-like family and is characterized by its ability to cleave peptide bonds at the carboxylic sides of aliphatic, aromatic, or hydrophobic amino acids [PubChem: SID 472051441]. The enzyme is notably stable and active across a wide range of pH values and temperatures, and it retains activity in the presence of detergents such as SDS, which makes it an essential tool in molecular biology for the digestion of proteins during nucleic acid purification [PubMed: 2385944]. While Proteinase K is not a therapeutic target for human disease, it is widely used in research and diagnostics, particularly for the detection of the protease-resistant infectious prion protein (PrPSc) in transmissible spongiform encephalopathies [PubMed: 10859301]. In laboratory settings, its activity can be inhibited by serine protease inhibitors such as phenylmethylsulfonyl fluoride (PMSF) or diisopropyl fluorophosphate (DFP), which act by covalently modifying the catalytic serine residue [Wikipedia: Proteinase K].
Inhibitors such as phenylmethylsulfonyl fluoride (PMSF) and diisopropyl fluorophosphate (DFP) target Proteinase K by covalently binding to the active site serine residue (Ser224), thereby irreversibly inactivating the enzyme's catalytic triad and preventing proteolysis.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteinase K (PROK).